Beyond visual acuity: New and complementary tests of visual function

Neurologic Clinics

Volumn 21, Issue 2, 2003, Pages 363-386

  Trick, Gary L ^a,b  

^a Henry Ford Health Science Center   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLOR VISION; DEPTH PERCEPTION; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; HUMAN; PERIMETRY; PRIORITY JOURNAL; REVIEW; VISION TEST; VISUAL ACUITY; VISUAL FIELD;

EID: 0038811790     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(02)00104-4     Document Type: Review

References (149)

1. Riggs LA. Visual acuity. In: Graham CH, editor. Vision and visual perception. New York: John Wiley & Sons; 1965.
2. Westheimer G. Visual acuity. In: Moses RA, editor. Adler's physiology of the eye: clinical applications. 7th edition. St. Louis: Mosby; 1981.
3. DeValois RL, DeValois KK. Spatial vision. Oxford (England): Oxford Science Publications; 1990.
4. Georgeson MA, Harris MG. Spatial selectivity of contrast adaptation: models and data. Vision Res 1984;24(7):729-41.
5. Regan D, Silver R, Murray TJ. Visual acuity and contrast sensitivity in multiple sclerosis-hidden visual loss: an auxiliary diagnostic test. Brain 1977;100(3):563-79.
6. Sachs MB, Nachmias J, Robson JG. Spatial-frequency channels in human vision. J Opt Soc Am 1971;61(9):1176-86.
7. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci 1988;2(3):187-99.
8. American Academy of Ophthalmology. Contrast sensitivity and glare testing in the evaluation of anterior segment disease. Ophthalmology 1990;97(9):1233-7.
9. Diether S, Gekeler F, Schaeffel F. Changes in contrast sensitivity induced by defocus and their possible relations to emmetropization in the chicken. Invest Ophthalmol Vis Sci 2001;42(12):3072-9.
10. Jimenez-Alfaro I, Gomez-Telleria G, Bueno JL, et al. Contrast sensitivity after posterior chamber phakic intraocular lens implantation for high myopia. J Refract Surg 2001;17(6):641-5.
11. Montes-Mico R, Charman WN. Choice of spatial frequency for contrast sensitivity evaluation after corneal refractive surgery. J Refract Surg 2001;17(6):646-51.
12. Superstein R, Boyaner D, Overbury O. Functional complaints, visual acuity, spatial contrast sensitivity, and glare disability in preoperative and postoperative cataract patients. J Cataract Refract Surg 1999;25(4):575-81.
13. Woods RL, Strang NC, Atchison DA. Measuring contrast sensitivity with inappropriate optical correction. Ophthalmic Physiol Opt 2000;20(6):442-51.
14. Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision function beyond acuity. Optom Vis Sci 1999;76(3):141-58.
15. Owsley C, Sekuler R, Siemsen D. Contrast sensitivity throughout adulthood. Vision Res 1983;23(7):689-99.
16. Sokol S, Moskowitz A, Skarf B, et al. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 1985;103(1):51-4.
17. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology 1988;95(5):693-8.
18. Abadi RV, Pantazidou M. Low contrast letter acuity in age-related maculopathy. Ophthalmic Physiol Opt 1996;16(6):455-9.
19. Kleiner RC, Enger C, Alexander MF, et al. Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol 1988;106(1):55-7.
20. Maaranen T, Mantyjarvi M. Contrast sensitivity in patients recovered from central serous chorioretinopathy. Int Ophthalmol 1999;23(1):31-5.
21. Atkin A, Bodis-Wollner I, Wolkstein M, et al. Abnormalities of central contrast sensitivity in glaucoma. Am J Ophthalmol 1979;88(2):205-11.
22. Zulauf M, Flammer J. Correlation of spatial contrast sensitivity and visual fields in glaucoma. Graefes Arch Clin Exp Ophthalmol 1993;231(3):146-50.
23. Antal A, Aita JF, Bodis-Wollner I. The paracentral visual field in multiple sclerosis: evidence for a deficit in interneuronal spatial summation? Vision Res 2001;41(13):1735-42.
24. Beck RW, Ruchman MC, Savino PJ, et al. Contrast sensitivity measurements in acute and resolved optic neuritis. Br J Ophthalmol 1984;68(10):756-9.
25. Bulens C, Meerwaldt JD, van der Wildt GJ, Keemink CJ. Spatial contrast sensitivity in unilateral cerebral ischemic lesions involving the posterior visual pathway. Brain 1989;112(2):507-20.
26. Gilmore GC, Whitehouse PJ. Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis. Optom Vis Sci. 1995;72(2):83-91.
27. Rizzo M, Anderson SW, Dawson J, et al. Vision and cognition in Alzheimer's disease. Neuropsychologia 2000;38(8):1157-69.
28. Hutton JT, Morris JL, Elias JW. Levodopa improves spatial contrast sensitivity in Parkinson's disease. Arch Neurol 1993;50(7):721-4.
29. Kupersmith MJ, Shakin E, Siegel IM, et al. Visual system abnormalities in patients with Parkinson's disease. Arch Neurol 1982;39(5):284-6.
30. Tagliati M, Brannan JR, Bodis-Wollner I. Contrast sensitivity in PD. Neurology 1992;42(5):1126-7.
31. Ansari EA, Sahni K, Etherington C, et al. Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements. Br J Ophthalmol 1999;83(6):688-91.
32. Westheimer G. Location and line orientation as distinguishable primitives in spatial vision. Proc R Soc Lond [Biol] 1996;263:503-8.
33. Enoch JM, Williams RA, Essock EA, et al. Hyperacuity perimetry. Assessment of macular function through ocular opacities. Arch Ophthalmol 1984;102(8):1164-8.
34. Essock EA, Williams RA, Enoch JM, et al. The effects of image degradation by cataract on vernier acuity. Invest Ophthalmol Vis Sci 1984;25(9):1043-50.
35. Ernst W. The dependence of critical flicker frequency and the rod threshold on the state of adaptation of the eye. Vision Res 1968;8(7):889-900.
36. Sharpe LT, Hofmeister J, Fach CC, et al. Spatial relations of flicker signals in the two rod pathways in man. J Physiol 1994;474(3):421-31.
37. Breton ME, Wilson TW, Wilson R, et al. Temporal contrast sensitivity loss in primary open-angle glaucoma and glaucoma suspects. Invest Ophthalmol Vis Sci 1991;32(11):2931-41.
38. Cursiefen C, Horn F, Junemann AG, et al. Reduced recovery of temporal contrast sensitivity after flicker stress in patients with glaucoma. J Glaucoma 2000;9(4):296-302.
39. Velten IM, Korth M, Horn FK, et al. Temporal contrast sensitivity with peripheral and central stimulation in glaucoma diagnosis. Br J Ophthalmol 1999;83(2):199-205.
40. Horn F, Martus P, Korth M. Comparison of temporal and spatiotemporal contrast-sensitivity tests in normal subjects and glaucoma patients. Ger J Ophthalmol 1995;4(2):97-102.
41. Bodis-Wollner I, Marx MS, Mitra S, et al. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987;110(Pt 6):1675-98.
42. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci 1990;13(7):296-302.
43. Mestre D, Blin O, Serratrice G, et al. Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease. Neurology 1990;40(11):1710-4.
44. Russell MH, Murray IJ, Metcalfe RA, et al. The visual defect in multiple sclerosis and optic neuritis. A combined psychophysical and electrophysiological investigation. Brain 1991;114(Pt 6):2419-35.
45. Trauzettel-Klosinski S, Schupbach M, Aulhorn E. Standardization of the Tubingen flicker test. Graefes Arch Clin Exp Ophthalmol 1989;227(3):221-9.
46. Vingrys AJ, Pesudovs K. Localized scotomata detected with temporal modulation perimetry in central serous chorioretinopathy. Aust N Z J Ophthalmol 1999;27(2):109-16.
47. Di Leo MA, Caputo S, Falsini B, et al. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care 1992;15(5):620-5.
48. Schwartz BD, McGinn T, Winstead DK. Disordered spatiotemporal processing in schizophrenics. Biol Psychiatry 1987;22(6):688-98.
49. Felius J, Swanson WH. Photopic temporal processing in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1999;40(12):2932-44.
50. Atkinson J, King J, Braddick O, et al. A specific deficit of dorsal stream function in Williams' syndrome. Neuroreport 1997;8(8):1919-22.
51. Marcar VL, Zihl J, Cowey A. Comparing the visual deficits of a motion blind patient with the visual deficits of monkeys with area MT removed. Neuropsychologia 1997;35(11):1459-65.
52. Nawrot M, Rizzo M, Rockland KS, et al. A transient deficit of motion perception in human. Vision Res 2000;40(24):3435-46.
53. Turano K, Wang X. Motion thresholds in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1992;33(8):2411-22.
54. Trick GL, Steinman SB, Amyot M. Motion perception deficits in glaucomatous optic neuropathy. Vision Res 1995;35(15):2225-33.
55. Wojciechowski R, Trick GL, Steinman SB. Topography of the age-related decline in motion sensitivity. Optom Vis Sci 1995;72(2):67-74.
56. Nakayama K, Tyler CW. Psychophysical isolation of movement sensitivity by removal of familiar position cues. Vision Res 1981;21(4):427-33.
57. Bosworth CF, Sample PA, Gupta N, et al. Motion automated perimetry identifies early glaucomatous field defects. Arch Ophthalmol 1998;116(9):1153-8.
58. Bullimore MA, Wood JM, Swenson K. Motion perception in glaucoma. Invest Ophthalmol Vis Sci 1993;34(13):3526-33.
59. Joffe KM, Raymond JE, Chrichton A. Motion coherence perimetry in glaucoma and suspected glaucoma. Vision Res 1997;37(7):955-64.
60. Silverman SE, Trick GL, Hart WM Jr. Motion perception is abnormal in primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1990;31(4):722-9.
61. Gilmore GC, Wenk HE, Naylor LA, et al. Motion perception and Alzheimer's disease. J Gerontol 1994;49(2):P52-7.
62. Rizzo M, Nawrot M. Perception of movement and shape in Alzheimer's disease. Brain 1998;121(Pt 12):2259-70.
63. Trick GL, Silverman SE. Visual sensitivity to motion: age-related changes and deficits in senile dementia of the Alzheimer type. Neurology 1991;41(9):1437-40.
64. Nathans J, Merbs SL, Sung CH, et al. Molecular genetics of human visual pigments. Annu Rev Genet 1992;26:403-24.
65. Nathans J. The evolution and physiology of human color vision: insights from molecular genetic studies of visual pigments. Neuron 1999;24(2):299-312.
66. Yokoyama S. Molecular evolution of vertebrate visual pigments. Prog Retin Eye Res 2000;19(4):385-419.
67. Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 1996;100(1):1-11.
68. Vu BL, Easterbrook M, Hovis JK. Detection of color vision defects in chloroquine retinopathy. Ophthalmology 1999;106(9):1799-803.
69. Clarke S, Walsh V, Schoppig A, Assal G, et al. Colour constancy impairments in patients with lesions of the prestriate cortex. Exp Brain Res 1998;123(1-2):154-8.
70. Ruttiger L, Braun DI, Gegenfurtner KR, et al. Selective color constancy deficits after circumscribed unilateral brain lesions. J Neurosci 1999;15;19(8):3094-106.
71. Adams AJ, Verdon WA, Sprivey BE. Color vision. In: Tasman W, Jaeger EA, editors. Duane's foundations of clinical ophthalmology, vol. 2. Philadelphia: Lippincott-Raven; 1997.
72. Foster DH, editor. Inherited and acquired colour vision deficiencies: fundamental aspects and clinical studies. Boca Raton (FL): CRC Press; 1991.
73. Katz B. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Trans Am Ophthalmol Soc 1995;93:685-708.
74. Anderson DR. Perimetry with and without automation. St, Louis: CV Mosby; 1987.
75. Enoch JM. The two-color threshold technique of Stiles and derived color component mechanisms. In: Jameson D, Hurvich LM, editors. Handbook of sensory physiology, vol. VII/4. Berlin: Springer-Verlag; 1972.
76. Demirel S, Johnson CA. Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients. Am J Ophthalmol 2001;131(6):709-15.
77. Johnson CA. Diagnostic value of short-wavelength automated perimetry. Curr Opin Ophthalmol 1996;7(2):54-8.
78. Sample PA. Short-wavelength automated perimetry: it's role in the clinic and for understanding ganglion cell function. Prog Retin Eye Res 2000;19(4):369-83.
79. Soliman MA, de Jong LA, Ismaeil AA, et al. Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage. Ophthalmology 2002;109(3):444-54.
80. Hutchings N, Hosking SL, Wild JM, et al. Long-term fluctuation in short-wavelength automated perimetry in glaucoma suspects and glaucoma patients. Invest Ophthalmol Vis Sci 2001;42(10):2332-7.
81. Wild J. Short wavelength automated perimetry. Acta Ophthalmol Scand 2001;79(6):546-59.
82. Girkin CA, Emdadi A, Sample PA, et al. Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping. Arch Ophthalmol 2000;118(9):1231-6.
83. Johnson CA, Brandt JD, Khong AM, et al. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results. Arch Ophthalmol 1995;113(1):704.
84. Mansberger SL, Sample PA, Zangwill L, et al. Achromatic and short-wavelength automated perimetry in patients with glaucomatous large cups. Arch Ophthalmol 1999;117(11):1473-7.
85. Remky A, Lichtenberg K, Elsner AE, et al. Short wavelength automated perimetry in age related maculopathy. Br J Ophthalmol 2001;85(12):1432-6.
86. Hudson C, Flanagan JG, Turner GS, et al. Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema. Diabetologia 1998;41(8):918-28.
87. Remky A, Arend O, Hendricks S. Short-wavelength automated perimetry and capillary density in early diabetic maculopathy. Invest Ophthalmol Vis Sci 2000;41(1):274-81.
88. Keltner JL, Johnson CA. Short-wavelength automated perimetry in neuro-ophthalmologic disorders. Arch Ophthalmol 1995;113(4):475-81.
89. Plummer DJ, Sample PA, Arevalo JF, et al. Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol 1996;122(4):542-9.
90. Frisen L. High-pass resolution targets in peripheral vision. Ophthalmology 1987;94(9):1104-8.
91. Wall M. High-pass resolution perimetry in optic neuritis. Invest Ophthalmol Vis Sci 1991;32(9):2525-9.
92. Martinez GA, Sample PA, Weinreb RN. Comparison of high-pass resolution perimetry and standard automated perimetry in glaucoma. Am J Ophthalmol 1995;119(2):195-201.
93. Sample PA, Ahn DS, Lee PC, et al. High-pass resolution perimetry in eyes with ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol 1992;113(3):309-16.
94. Chauhan BC, House PH, McCormick TA, et al. Comparison of conventional and high-pass resolution perimetry in a prospective study of patients with glaucoma and healthy controls. Arch Ophthalmol 1999;117(1):24-33.
95. Maddess T, Hemmi JM, James AC. Evidence for spatial aliasing effects in the Y-like cells of the magnocellular visual pathway. Vision Res 1998;38(12):1843-59.
96. Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol 2000;129(3):314-22.
97. Trible JR, Schultz RO, Robinson JC, et al. Accuracy of glaucoma detection with frequency-doubling perimetry. Am J Ophthalmol 2000;129(6):740-5.
98. Landers J, Goldberg I, Graham S. A comparison of short wavelength automated perimetry with frequency doubling perimetry for the early detection of visual field loss in ocular hypertension. Clin Experiment Ophthalmol 2000;28(4):248-52.
99. Fujimoto N, Adachi-Usami E. Frequency doubling perimetry in resolved optic neuritis. Invest Ophthalmol Vis Sci 2000;41(9):2558-60.
100. Sheu SJ, Chen YY, Lin HC, et al. Frequency doubling technology perimetry in retinal diseases-preliminary report. Kaohsiung J Med Sci 2001;17(1):25-8.
101. Thomas D, Thomas R, Muliyil JP, et al. Role of frequency doubling perimetry in detecting neuro-ophthalmic visual field defects. Am J Ophthalmol 2001;131(6):734-41.
102. Ball K, Owsley C, Sloane ME, et al. Visual attention problems as a predictor of vehicle crashes in older drivers. Invest Ophthalmol Vis Sci 1993;34(11):3110-23.
103. Ball K, Owsley C. The useful field of view test: a new technique for evaluating age-related declines in visual function. J Am Optom Assoc 1993;64(1):71-9.
104. Owsley C, Ball K, McGwin G Jr, et al. Visual processing impairment and risk of motor vehicle crash among older adults. JAMA 1998;279(14):1083-8.
105. Owsley C, McGwin G Jr, Ball K. Vision impairment, eye disease, and injurious motor vehicle crashes in the elderly. Ophthalmic Epidemiol 1998;5(2):101-13.
106. Ball KK, Beard BL, Roenker DL, et al. Age and visual search: expanding the useful field of view. J Opt Soc Am [A] 1988;5(12):2210-9.
107. Sims RV, Owsley C, Allman RM, et al. A preliminary assessment of the medical and functional factors associated with vehicle crashes by older adults. J Am Geriatr Soc 1998;46(5):556-61.
108. Mendez MF. Visuoperceptual function in visual agnosia. Neurology 1988;38(11):1754-9.
109. Riggs LA. Continuous and reproducible records of the electrical activity of the human retina. Proc Soc Exp Biol Med 1941;48:204-7.
110. Harding GFA. History of visual evoked cortical testing. In: Heckenlively JR, Arden GA, editors. Principles and practice of clinical visual electrophysiology. St. Louis: Mosby; 1991.
111. Fishman GA, Birch DG, Holder GE, et al. Electrophysiologic testing in disorders of the retina, optic nerve and visual pathway. 2nd edition. San Francisco: Foundation of the American Academy of Ophthalmology; 2001.
112. Heckenlively JR, Arden GA, editors. Principles and practice of clinical visual electrophysiology 1991.
113. Miyake Y, Shiroyama N, Ota I, et al. Local macular electroretinographic responses in idiopathic central serous chorioretinopathy. Am J Ophthalmol 1988;106:546-50.
114. Biersdorf WR. Temporal factors in the foveal ERG. Curr Eye Res 1981-82;1(12):717-22.
115. Sandberg MA, Jacobson SG, Berson EL. Foveal cone electroretinograms in retinitis pigmentosa and juvenile maular degeneration. Am J Ophthalmol 1979;88(4):702-7.
116. Falsini B, Serrao S, Fadda A, et al. Focal electroretinograms and fundus appearance in nonexudative age-related macular degeneration. Quantitative relationship between retinal morphology and function. Graefes Arch Clin Exp Ophthalmol 1999;237(3):193-200.
117. Birch DG, Jost BF, Fish GE. The focal electroretinogram in fellow eyes of patients with idiopathic macular holes. Arch Ophthalmol 1988;106(11):1558-63.
118. Porciatti V. Non-linearities in the focal ERG evoked by pattern and uniform-field stimulation. Their variation in retinal and optic nerve dysfunction. Invest Ophthalmol Vis Sci 1987;28(8):1306-13.
119. Vaegan, Billson F, Kemp S, et al. Macular electroretinograms: their accuracy, specificity and implementation for clinical use. Aust J Ophthalmol 1984;12(4):359-72.
120. Maffei L, Fiorentini A. Electroretinographic responses to alternating gratings before and after section of the optic nerve. Science 1981;211:953-5.
121. Maffei L, Fiorentini A. Electroretinographic responses to alternating gratings in the cat. Exp Brain Res 1982;48(3):327-34.
122. Fiorentini A, Maffei L, Pirchio M, et al. The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway. Invest Ophthalmol Vis Sci 1981;21(3):490-3.
123. Sieving PA, Steinberg RH. Contribution from proximal retina to intraretinal pattern ERG: the M-wave. Invest Ophthalmol Vis Sci 1985;26(11):1642-7.
124. Schuurmans RP, Berninger T. Luminance and contrast responses recorded in man and cat. Doc Ophthalmol 1985;59(2):187-97.
125. Marmor MF, Holder GE, Porciatti V, et al. Guidelines for basic pattern electroretinography. Recommendations by the International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 1995-96;91(4):291-8.
126. Drasdo N, Aldebasi YH, Chiti Z, et al. The s-cone PHNR and pattern ERG in primary open angle glaucoma. Invest Ophthalmol Vis Sci 2001;42(6):1266-72.
127. Graham SL, Wong VA, Drance SM, et al. Pattern electroretinograms from hemifields in normal subjects and patients with glaucoma. Invest Ophthalmol Vis Sci 1994;35(9):3347-56.
128. Trick GL. Retinal potentials in patients with primary open-angle glaucoma: physiological evidence for temporal frequency tuning deficits. Invest Ophthalmol Vis Sci 1985;26(12):1750-8.
129. O'Donaghue E, Arden GB, O'Sullivan F, et al. The pattern electroretinogram in glaucoma and ocular hypertension. Br J Ophthalmol 1992;76(7):387-94.
130. Trick GL. Pattern reversal retinal potentials in ocular hypertensives at high and low risk of developing glaucoma. Doc Ophthalmol 1987;65(1):79-85.
131. Falsini B, Porrello G, Porciatti V, et al. The spatial tuning of steady state pattern electroretinogram in multiple sclerosis. Eur J Neurol 1999;6(2):151-62.
132. Parisi V, Manni G, Gandolfi SA, et al. Visual function correlates with nerve fiber layer thickness in eyes affected by ocular hypertension. Invest Ophthalmol Vis Sci 1999;40(8):1828-33.
133. Froehlich J, Kaufman DI. Use of pattern electroretinography to differentiate acute optic neuritis from acute anterior ischemic optic neuropathy. Electroencephalogr Clin Neurophysiol 1994;92(6):480-6.
134. Katz B, Rimmer S, Iragui V, et al. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann Neurol 1989;26(2):221-5.
135. Parisi V, Restuccia R, Fattapposta F, et al. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 2001;112(10):1860-7.
136. Trick GL, Barris MC, Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol 1989;26(2):226-31.
137. Nightingale S, Mitchell KW, Howe JW. Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiatry 1986;49(11):1280-7.
138. Falsini B, Tamburrelli C, Porciatti V, et al. Pattern electroretinograms and visual evoked potentials in idiopathic intracranial hypertension. Ophthalmologica 1992;205(4):194-203.
139. Parmar DN, Sofat A, Bowman R, et al. Visual prognostic value of the pattern electroretinogram in chiasmal compression. Br J Ophthalmol 2000;84(9):1024-6.
140. Si YJ, Kishi S, Aoyagi K. Assessment of macular function by multifocal electroretinogram before and after macular hole surgery. Br J Ophthalmol 1999;83(4):420-4.
141. Kretschmann U, Seeliger MW, Ruether K, et al. Multifocal electroretinography in patients with Stargardt's macular dystrophy. Br J Ophthalmol 1998;82(3):267-75.
142. Seeliger M, Kretschmann U, Apfelstedt-Sylla E, et al. Multifocal electroretinography in retinitis pigmentosa. Am J Ophthalmol 1998;125(2):214-26.
143. Seeliger MW, Kretschmann UH, Apfelstedt-Sylla E, et al. Implicit time topography of multifocal electroretinograms. Invest Ophthalmol Vis Sci 1998;39(5):718-23.
144. Holopigian K, Seiple W, Greenstein VC, et al. Local cone and rod system function in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2001;42(3):779-88.
145. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res 2000;19(5):607-46.
146. Klistorner A, Graham SL. Objective perimetry in glaucoma. Ophthalmology 2000;107(12):2283-99.
147. Klistorner AI, Graham SL, Grigg JR, et al. Multifocal topographic visual evoked potential: improving objective detection of local visual field defects. Invest Ophthalmol Vis Sci 1998;39(6):937-50.
148. Klistorner AI, Graham SL. Early magnocellular loss in glaucoma demonstrated using the pseudorandomly stimulated flash visual evoked potential. J Glaucoma 1999;8(2):140-8.
149. Betsuin Y, Mashima Y, Ohde H, et al. Clinical application of the multifocal VEPs. Curr Eye Res 2001;22(1):54-63.